The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Atyr Pharma Inc shares valued at $9,276 were purchased by DENYES NANCY on Jun 05 ’24. At $1.86 per share, DENYES NANCY acquired 5,000 shares. The insider’s holdings grew to 22,267 shares worth approximately $41193.950000000004 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Shukla Sanjay purchased 20,000 shares, netting a total of over 36,140 in proceeds. Following the buying of shares at $1.81 each, the insider now holds 136,548 shares.
Before that, Broadfoot Jill Marie had added 5,000 shares to its account. In a trade valued at $8,950, the Chief Financial Officer bought Atyr Pharma Inc shares for $1.79 each. Upon closing the transaction, the insider’s holdings increased to 5,000 shares, worth approximately $51726.0.
As published in a research note from Oppenheimer on July 05, 2023, Atyr Pharma Inc [ATYR] has been rated down from an Outperform to a Perform. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid October. As of September 21, 2021, Piper Sandler has initiated its “an Overweight” rating for ATYR. Earlier on May 10, 2021, Laidlaw initiated its rating. Their recommendation was “a Buy” for ATYR stock.
Analyzing ATYR Stock Performance
During the last five days, there has been a drop of approximately -0.54%. Over the course of the year, Atyr Pharma Inc shares have jumped approximately 31.21%. Shares of the company reached a 52-week high of $2.1500 on 03/20/24 and a 52-week low of $1.3900 on 01/02/24. A 50-day SMA is recorded $1.7594, while a 200-day SMA reached $1.5935.
Support And Resistance Levels for Atyr Pharma Inc (ATYR)
According to the 24-hour chart, there is a support level at 1.8200, which, if violated, would cause prices to drop to 1.7900. In the upper region, resistance lies at 1.9100. The next price resistance is at 1.9700. RSI (Relative Strength Index) is 51.10 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0571, which suggests the price will decrease in the coming days. Percent R is at 52.38%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
Which companies own the most shares of Atyr Pharma Inc (ATYR)?
On August 17, 2020, H.C. Wainwright assigned a price target of “a Buy” to the stock and upgraded coverage with a $13.
